Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy an

Indication
Generalized Myasthenia Gravis

Other upcoming events for IMVT

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficac

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy an — IMVT Phase 3 Readout | BioSniper